Audiological evalutation of the cochlear nerve with brainstem evoked response audiometry in patients with COVID-19

dc.contributor.authorTas, Abdurrahim
dc.contributor.authorHaznedar, Berzan
dc.contributor.authorTuncer, Mehmet Cudi
dc.date.accessioned2024-04-24T17:15:11Z
dc.date.available2024-04-24T17:15:11Z
dc.date.issued2022
dc.departmentDicle Üniversitesien_US
dc.description.abstractPurpose: In this clinical study, it was aimed to prospectively evaluate the cochlear nerve with brainstem evoked response audiometry (BERA) in terms of audiological ailments in patients with COVID-19. Although the relationship of COVID-19 with tinnutus and hearing loss has been investigated since the day this infectious respiratory disease emerged, its relationship with BERA has not been fully demonstrated from a neurological perspective.Methods: It was carried out on a group of patients who had COVID-19 in the last 6 months between February and August 2021 in Diyarbakir Gazi Yasargil Training and Research Hospital. Patients between the ages of 18-50, who applied to the otorhinolaryngology and neurology clinic and had COVID-19 in the last 6 months, were selected. The COVID-19 group of our study consisted of 30 patients, 18 males and 12 females, who had had COVID-19 disease in the last 6 months, and 30 healthy individuals, 16 males and 14 females, as the control group.Results: In patients with COVID-19, the evaluation of the destruction of the cochlear nerve with BERA showed that there was a statistically significant prolongation in I-III and I-V interpeaks at 70, 80 and 90 db nhl.Conclusions: Statistically significant prolongation of especially I-III and I-V Interpeaks in BERA showed that COVID-19 has the potential to cause neuropathy. We believe that the BERA test should be considered in the neurological evaluation of cochlear nerve damage in patients with COVID-19 as a differential diagnosis.en_US
dc.identifier.doi10.12871/000398292022342
dc.identifier.endpage114en_US
dc.identifier.issn0003-9829
dc.identifier.issue3-4en_US
dc.identifier.pmid36881914
dc.identifier.scopus2-s2.0-85149524420
dc.identifier.scopusqualityQ4
dc.identifier.startpage106en_US
dc.identifier.urihttps://doi.org/10.12871/000398292022342
dc.identifier.urihttps://hdl.handle.net/11468/18368
dc.identifier.volume160en_US
dc.identifier.wosWOS:001046169600002
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherPisa Univ Pressen_US
dc.relation.ispartofArchives Italiennes De Biologie
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCovid-19en_US
dc.subjectSars-Cov-2en_US
dc.subjectBrainstem Evoked Response Audiometryen_US
dc.subjectHearing Losten_US
dc.subjectNeuropathyen_US
dc.subjectIntroductionen_US
dc.titleAudiological evalutation of the cochlear nerve with brainstem evoked response audiometry in patients with COVID-19en_US
dc.titleAudiological evalutation of the cochlear nerve with brainstem evoked response audiometry in patients with COVID-19
dc.typeArticleen_US

Dosyalar